232 related articles for article (PubMed ID: 27018342)
1. Angiotensin-converting enzyme 2 ameliorates renal fibrosis by blocking the activation of mTOR/ERK signaling in apolipoprotein E-deficient mice.
Chen LJ; Xu YL; Song B; Yu HM; Oudit GY; Xu R; Zhang ZZ; Jin HY; Chang Q; Zhu DL; Zhong JC
Peptides; 2016 May; 79():49-57. PubMed ID: 27018342
[TBL] [Abstract][Full Text] [Related]
2. Deletion of angiotensin-converting enzyme 2 exacerbates renal inflammation and injury in apolipoprotein E-deficient mice through modulation of the nephrin and TNF-alpha-TNFRSF1A signaling.
Jin HY; Chen LJ; Zhang ZZ; Xu YL; Song B; Xu R; Oudit GY; Gao PJ; Zhu DL; Zhong JC
J Transl Med; 2015 Aug; 13():255. PubMed ID: 26245758
[TBL] [Abstract][Full Text] [Related]
3. Cardiac protective effects of irbesartan via the PPAR-gamma signaling pathway in angiotensin-converting enzyme 2-deficient mice.
Zhang ZZ; Shang QH; Jin HY; Song B; Oudit GY; Lu L; Zhou T; Xu YL; Gao PJ; Zhu DL; Penninger JM; Zhong JC
J Transl Med; 2013 Sep; 11():229. PubMed ID: 24067190
[TBL] [Abstract][Full Text] [Related]
4. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction.
Zhong J; Basu R; Guo D; Chow FL; Byrns S; Schuster M; Loibner H; Wang XH; Penninger JM; Kassiri Z; Oudit GY
Circulation; 2010 Aug; 122(7):717-28, 18 p following 728. PubMed ID: 20679547
[TBL] [Abstract][Full Text] [Related]
5. Antagonism of angiotensin 1-7 prevents the therapeutic effects of recombinant human ACE2.
Patel VB; Takawale A; Ramprasath T; Das SK; Basu R; Grant MB; Hall DA; Kassiri Z; Oudit GY
J Mol Med (Berl); 2015 Sep; 93(9):1003-13. PubMed ID: 25874965
[TBL] [Abstract][Full Text] [Related]
6. Prevention of angiotensin II-mediated renal oxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2.
Zhong J; Guo D; Chen CB; Wang W; Schuster M; Loibner H; Penninger JM; Scholey JW; Kassiri Z; Oudit GY
Hypertension; 2011 Feb; 57(2):314-22. PubMed ID: 21189404
[TBL] [Abstract][Full Text] [Related]
7. Loss of angiotensin-converting enzyme 2 enhances TGF-β/Smad-mediated renal fibrosis and NF-κB-driven renal inflammation in a mouse model of obstructive nephropathy.
Liu Z; Huang XR; Chen HY; Penninger JM; Lan HY
Lab Invest; 2012 May; 92(5):650-61. PubMed ID: 22330342
[TBL] [Abstract][Full Text] [Related]
8. Effect of ACE2 and angiotensin-(1-7) in a mouse model of early chronic kidney disease.
Dilauro M; Zimpelmann J; Robertson SJ; Genest D; Burns KD
Am J Physiol Renal Physiol; 2010 Jun; 298(6):F1523-32. PubMed ID: 20357030
[TBL] [Abstract][Full Text] [Related]
9. Angiotensin-(1-7) prevents systemic hypertension, attenuates oxidative stress and tubulointerstitial fibrosis, and normalizes renal angiotensin-converting enzyme 2 and Mas receptor expression in diabetic mice.
Shi Y; Lo CS; Padda R; Abdo S; Chenier I; Filep JG; Ingelfinger JR; Zhang SL; Chan JS
Clin Sci (Lond); 2015 May; 128(10):649-63. PubMed ID: 25495544
[TBL] [Abstract][Full Text] [Related]
10. Murine recombinant angiotensin-converting enzyme 2: effect on angiotensin II-dependent hypertension and distinctive angiotensin-converting enzyme 2 inhibitor characteristics on rodent and human angiotensin-converting enzyme 2.
Ye M; Wysocki J; Gonzalez-Pacheco FR; Salem M; Evora K; Garcia-Halpin L; Poglitsch M; Schuster M; Batlle D
Hypertension; 2012 Sep; 60(3):730-40. PubMed ID: 22777933
[TBL] [Abstract][Full Text] [Related]
11. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis protects against lung fibrosis by inhibiting the MAPK/NF-κB pathway.
Meng Y; Yu CH; Li W; Li T; Luo W; Huang S; Wu PS; Cai SX; Li X
Am J Respir Cell Mol Biol; 2014 Apr; 50(4):723-36. PubMed ID: 24168260
[TBL] [Abstract][Full Text] [Related]
12. Angiotensin-converting enzyme 2/angiotensin-(1-7)/Mas axis prevents lipopolysaccharide-induced apoptosis of pulmonary microvascular endothelial cells by inhibiting JNK/NF-κB pathways.
Li Y; Cao Y; Zeng Z; Liang M; Xue Y; Xi C; Zhou M; Jiang W
Sci Rep; 2015 Feb; 5():8209. PubMed ID: 25644821
[TBL] [Abstract][Full Text] [Related]
13. Targeting the degradation of angiotensin II with recombinant angiotensin-converting enzyme 2: prevention of angiotensin II-dependent hypertension.
Wysocki J; Ye M; Rodriguez E; González-Pacheco FR; Barrios C; Evora K; Schuster M; Loibner H; Brosnihan KB; Ferrario CM; Penninger JM; Batlle D
Hypertension; 2010 Jan; 55(1):90-8. PubMed ID: 19948988
[TBL] [Abstract][Full Text] [Related]
14. Loss of angiotensin-converting enzyme 2 exacerbates myocardial injury via activation of the CTGF-fractalkine signaling pathway.
Song B; Zhang ZZ; Zhong JC; Yu XY; Oudit GY; Jin HY; Lu L; Xu YL; Kassiri Z; Shen WF; Gao PJ; Zhu DL
Circ J; 2013; 77(12):2997-3006. PubMed ID: 24161906
[TBL] [Abstract][Full Text] [Related]
15. Interaction between TGF-β and ACE2-Ang-(1-7)-Mas pathway in high glucose-cultured NRK-52E cells.
Chou CH; Chuang LY; Lu CY; Guh JY
Mol Cell Endocrinol; 2013 Feb; 366(1):21-30. PubMed ID: 23174757
[TBL] [Abstract][Full Text] [Related]
16. ACE2 exerts anti-obesity effect via stimulating brown adipose tissue and induction of browning in white adipose tissue.
Kawabe Y; Mori J; Morimoto H; Yamaguchi M; Miyagaki S; Ota T; Tsuma Y; Fukuhara S; Nakajima H; Oudit GY; Hosoi H
Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1140-E1149. PubMed ID: 31638856
[TBL] [Abstract][Full Text] [Related]
17. Angiotensin-converting enzyme 2 regulates renal atrial natriuretic peptide through angiotensin-(1-7).
Bernardi S; Burns WC; Toffoli B; Pickering R; Sakoda M; Tsorotes D; Grixti E; Velkoska E; Burrell LM; Johnston C; Thomas MC; Fabris B; Tikellis C
Clin Sci (Lond); 2012 Jul; 123(1):29-37. PubMed ID: 22288735
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin-(1-7) Attenuates Kidney Injury Due to Obstructive Nephropathy in Rats.
Kim CS; Kim IJ; Bae EH; Ma SK; Lee J; Kim SW
PLoS One; 2015; 10(11):e0142664. PubMed ID: 26556707
[TBL] [Abstract][Full Text] [Related]
19. Protective role of ACE2-Ang-(1-7)-Mas in myocardial fibrosis by downregulating K
Wang LP; Fan SJ; Li SM; Wang XJ; Gao JL; Yang XH
Pflugers Arch; 2016 Nov; 468(11-12):2041-2051. PubMed ID: 27592222
[TBL] [Abstract][Full Text] [Related]
20. Angiotensin-converting-enzyme 2 inhibits liver fibrosis in mice.
Osterreicher CH; Taura K; De Minicis S; Seki E; Penz-Osterreicher M; Kodama Y; Kluwe J; Schuster M; Oudit GY; Penninger JM; Brenner DA
Hepatology; 2009 Sep; 50(3):929-38. PubMed ID: 19650157
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
